Evaluating the Combined Effect of Oral Premedications on Inferior Alveolar Nerve Block Effectiveness
Conditions
- Symptomatic Irreversible Pulpitis
Interventions
- DIETARY_SUPPLEMENT: Patients in this group will receive an oral placebo (e.g., sugar tablet or inert capsule) 1 hour before the IANB
- DRUG: Patients will receive ibuprofen (400-600 mg, standard therapeutic dose) orally, 1 hour prior to IANB
- DRUG: Group III - Serratiopeptidase Group
- COMBINATION_PRODUCT: Group IV - Combination Group (Ibuprofen and Serratiopeptidase)
Sponsor
Zahoor khan
Collaborators